Teprotumumab-associated aural fullness and ageusia: A case report of persistent complications following thyroid eye disease treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Teprotumumab-associated aural fullness and ageusia: A case report of persistent complications following thyroid eye disease treatment

Published:2024-10 Issue:3 Volume:1 Page:100047
ISSN:2950-2535
Container-title:AJO International
language:en
Short-container-title:AJO International

Author:

Hsiou David A.,Terrell Jesse A.^ORCID,Nolan Ryan P.^ORCID,Mudie Lucy I.^ORCID,Yen Michael T.

Funder

Research to Prevent Blindness

Publisher

Elsevier BV

Reference15 articles.

1. Hearing dysfunction after treatment with teprotumumab for thyroid eye disease;Sears;Am J Ophthalmol,2022

2. Teprotumumab and hearing loss: case series and proposal for audiologic monitoring;Belinsky;Ophthal Plast Reconstr Surg,2021

3. Teprotumumab for thyroid-associated ophthalmopathy;Smith;N Engl J Med,2017

4. Teprotumumab for the treatment of active thyroid eye disease;Douglas;N Engl J Med,2020

5. Teprotumumab: interpreting the clinical trials in the context of thyroid eye disease pathogenesis and current therapies;Winn;Ophthalmology,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP